- Home
- BLRX vs MNY Comparison
BLRX vs MNY Comparison
Compare BLRX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLRX | MNY |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 38.4M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BLRX | MNY |
|---|---|---|
| Price | $2.52 | $0.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $19.00 | $4.00 |
| AVG Volume (30 Days) | 19.9K | ★ 30.0K |
| Earning Date | 05-26-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $0.60 |
| 52 Week High | $4.56 | $1.60 |
Technical Indicators
Market Signals| Indicator | BLRX | MNY |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 23.42 |
| Support Level | $2.18 | N/A |
| Resistance Level | $3.04 | $0.91 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 36.11 | 23.95 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About MNY MoneyHero Limited
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.